News Releases

Novel SARS CoV-2 Saliva Collection Devices Address COVID-19 Testing Challenges, Improving Lab Efficiency and PCR Test Performance

January 26, 2021

GenTegra, LLC, announced today a study on the development and characterization of two novel COVID-19 saliva sample collection tube devices. The publication is posted on medRxiv, the pre-print server for health sciences.

GenTegra, LLC Announces New SARS-CoV-2 Sample Stabilization and Transport Products to Facilitate Expansion of COVID-19 Testing

June 16, 2020

Gentegra announce two new viral stabilization products, GenTegra® GTR-STM™ and GenTegra® GTR-VTM™. Products address sample transport and stability challenges associated with SARS-CoV-2 samples, and…

Exclusive Worldwide Distribution Agreement with ITSI Bioscience LLC.

October 29, 2019

Exclusive Worldwide distribution agreement with ITSI Biosciences expands Gentegra’s customer reach…

GenTegra LLC $2.8M SBIR Grant for RNA Collection Cards

April 25, 2019

GenTegra awarded a Phase IIb Small Business Innovation Research (SBIR) grant for $2.8M from NIAID. This three-year grant will fund the development of filter paper technologies for collection and stabilization of RNA …

GenTegra Launches Ahlstrom GenSaver 2.0 Forensic Card

November 14, 2017

Antimicrobial properties included to provide high quality protection of the DNA for >20 years, an important requirement for the forensic market…

GenTegra, LLC $1.8M SBIR Grant for RNA

March 15, 2017

The two-year grant will fund the development of filter paper technology for the collection and stabilization of RNA virus in whole blood and plasma at ambient temperatures …

Ahlstrom GenSaver™ Collection Card for Dried Blood Spots (DBS)

February 2, 2016

GenTegra LLC and Ahlstrom have launched a new DBS collection card that provides superior protection for the DNA in DBS. Now stable without freezing for >20 years…

Texas A&M AgriLife Research and GenTegra LLC are Awarded Contract Continuation

November 2, 2015

Gentegra announces two new viral stabilization products, GenTegra® GTR-STM™ and GenTegra® GTR-VTM™. Products address sample transport and stability challenges associated with SARS-CoV-2 samples, and…

Tasso and GenTegra Simplify Blood Draws, Awarded $3M Expansion

Tasso, Inc., a medtech start-up developing the HemoLink™, a small disposable device to simplify blood sampling, has secured an additional $2.9M in grant funding to advance its HemoLink technology…

Protect Your RNA Samples Immediately, and for All its Tomorrows

March 21, 2014

GenTegra LLC, Pleasanton, CA, announces launch of GenTegra®-RNA dry Bulk. GenTegra-RNA is groundbreaking technology for the stabilization, transport and storage of purified RNA….

Translate »